^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
OncobiotaLUNG assay

Company:
Micronoma
Type:
Laboratory Developed Test

Details

Evidence
OncobiotaLUNG is a minimally invasive and high-precision microbiome-driven liquid biopsy™ method is designed to help detect cancer even in its earliest stages. Micronoma’s patent-pending method, analyzing a multitude of circulating microbial markers linked to the tumor tissue as well as the host response to the cancer, has the potential to provide an advantage in early-stage cancer detection.
Cancer:
Lung Cancer
Method:
Microbiome driven liquid biopsy method